CASIF
CASI Pharmaceuticals, Inc.Company with tickers: CASIF
CIK
1962738
CUSIP
G1933S101
Shares Outstanding
20,555,873
13F Activity (30d)
3 filings
2 filers
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year, share counts where the company tagged them, and the buyback program's authorization. Amounts come exclusively from tagged SEC data, so years a company never tagged show no figure.
Program Authorized
$10,000,000
as of 2021-12-15
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2023-12-31 | $278,000 | 20-F, filed 2026-05-15 |
| 2022-12-31 | $3,267,000 | 20-F, filed 2025-03-31 |